How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT
Authors:
- 4 April 2016
- journal article
- review article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 51 (8) , 1041-1049
Abstract
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients frequently develop glucose intolerance and post-transplant diabetes mellitus (PTDM). The clinical importance of PTDM and its detrimental impact on HSCT outcomes are under-recognized. After allo-HSCT, various mechanisms can contribute to the development of PTDM. Here we review information about hyperglycemia and PTDM after allo-HSCT as well as PTDM after solid organ transplantation and describe ways to manage hyperglycemia/PTDM after allogeneic HSCT. Taking into consideration a lack of well-established evidence in the field of allo-HSCT, more studies should be conducted in the future, which will require closer multidisciplinary collaboration between hematologists, endocrinologists and nutritionists.Keywords
This publication has 112 references indexed in Scilit:
- Early Basal Insulin Therapy Decreases New-Onset Diabetes after Renal TransplantationJournal of the American Society of Nephrology, 2012
- Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivityBlood, 2012
- Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2012
- The impact of diabetes on the pathogenesis of sepsisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathNew England Journal of Medicine, 2011
- Vitamin D status among long-term survivors of hematopoietic cell transplantationBone Marrow Transplantation, 2011
- Increased Cardiometabolic Traits in Pediatric Survivors of Acute Lymphoblastic Leukemia Treated with Total Body IrradiationTransplantation and Cellular Therapy, 2010
- Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registryAnnals of the Rheumatic Diseases, 2010
- The Contribution of Malglycemia to Mortality among Allogeneic Hematopoietic Cell Transplant RecipientsTransplantation and Cellular Therapy, 2009
- High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantationBone Marrow Transplantation, 2008